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Introduction
Prenatal ultrasound is a powerful tool for detecting struc-
tural abnormalities in fetuses in trisomy 13 pregnancies
[1]. This article provides a comprehensive review of the
prenatal sonographic features of trisomy 13 in the sec-
ond and third trimesters, including holoprosencephaly
(HPE), brachycephaly, microcephaly, Dandy-Walker
complex (DWC) and posterior fossa abnormalities,
ventriculomegaly, neural tube defects (NTDs), facial cleft,
and micrognathia. The Table summarizes the frequencies
of second- and third-trimester sonographic features of
trisomy 13 pregnancies reported in the literature.
Holoprosencephaly
HPE is a developmental abnormality characterized by
congenital malformations of the forebrain and midface.
There are several types of HPE, ranging from severe
alobar HPE with cyclopia, ethmocephaly, cebocephaly
or premaxillary agenesis, to microforms with micro-
cephaly, corpus callosum agenesis/dysgenesis, mental
retardation, ocular hypotelorism, or a single maxillary
central incisor [2]. Chromosomal aberrations, Mendelian
mutations, X-linked inheritance and teratogens are all
well-known causes of HPE [3–7]. Cytogenetic abnor-
malities have been reported in 24–25% of infants born
with HPE, with trisomy 13 being the most common [8].
Reported chromosomal abnormalities associated with
HPE include trisomy 13, trisomy 18, triploidy, del(2p),
dup(3p), del(7q), del(13q), del(18p), del(21q), and
interstitial deletion of 14q13 [2,9–21].
The prevalence of HPE is about 1.2 per 10,000 reg-
istered births [22,23], and its prevalence in the second
trimester is about 1 per 8,000 [23]. Berry et al [24]
found chromosomal abnormalities in 28.9% (11/38)
of fetuses with HPE, including trisomy 13 (n = 8), tri-
somy 18 (n = 1), i(18q) (n = 1) and del(21q) (n = 1).
They also found that the karyotype was normal in all
12 cases with isolated HPE and in all five cases with
HPE and only facial defects, while the karyotype was
abnormal in 52.4% (11/21) of fetuses with extrafacial
malformations. Croen et al [22] found chromosomal
abnormalities in 41.3% (50/121) of registered births
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with HPE, including trisomy 13 (n = 38), trisomy 18
(n = 3), trisomy 21 (n = 1), triploidy (n = 1), 6q + (n = 1),
del(18p) (n = 1), del(13q) (n = 1), r(13) (n = 1), r(21)
(n = 1), t(1;2)(p13;p21) (n = 1) and der(15)t(3;15)
(q13.2;q26.3) (n = 1). Whiteford and Tolmie [25] re-
ported chromosomal abnormalities in 34.0% (17/50)
of registered births with HPE, including trisomy 13
(n=13), del(13q) (n=2) and del(7q) (n=2), while Odent
et al [26] found chromosomal abnormalities in 38.8%
(100/258) of HPE cases, including trisomy 13 (n = 64),
trisomy 18 (n =8), triploidy (n =8), abnormalities of 7q
(n = 9) and other rearrangements. Bullen et al [23]
detected chromosomal abnormalities in 37.7% (20/53)
of fetuses with HPE, including trisomy 13 (n = 15), tri-
somy 18 (n = 2), del(13q) (n = 2) and del(2p) (n = 1),
and Blaas et al [27] found abnormalities in 36.7%
(11/30) of such fetuses, including trisomy 13 (n = 5),
r(13) (n = 1), del(13q) (n = 1), triploidy (n = 1), partial
monosomy 14q (n = 1), partial monosomy 11p (n = 1)
and t(8;14)(q21.1;q24.1) (n =1). Chen et al [14] found
chromosomal abnormalities in 57.6% (34/59) of fetuses
with HPE, including trisomy 13 (n =19), mosaic trisomy
13 (n = 1), i(13q) (n = 1), trisomy 18 (n = 4), triploidy
(n = 2), del(7q) (n = 1), concomitant dup(3p) and del
(2q) (n = 2), concomitant dup(3p) and del(7q) (n = 2),
del(18p) (n=1), and del(14)(q13q21.1) (n=1). Trisomy
13 accounts for up to 75% of the chromosomal abnor-
malities associated with HPE [22–25]. In a meta-analysis
of 132 fetuses with prenatally detected HPE, Snijders
et al [28] reported chromosomal abnormalities in 33%
Table. Frequency of prenatal ultrasound features in six studies of fetuses with trisomy 13
Authors/Year of publication
Nicolaides et al Lehman et al De Vigan et al Tongsong et al Papp et al Watson et al
[33]/1992 [34]/1995 [32]/2001 [35]/2002 [30]/2006 [31]/2007
Fetuses, n 31 33 58 15 28 54
Gestational age (wk) 15–39 12–32 20–30 16–22 19.5 (average) 14–21
Features, n (%)
Brachycephaly 5 (16.1) – – – – –
Microcephaly 3 (9.7) 4 (12.1) – – – –
Holoprosencephaly 11 (35.5) 13 (39.4) 15 (25.9) 7 (46.7) 5 (17.9) 10 (18.5)
Posterior fossa cyst 6 (19.4) – – 1 (6.7) 2 (7.1) 4 (7.4)
Enlarged cisterna magna – 5 (15.2) – – – –
Dandy-Walker – – – – – 4 (7.4)
malformation
Ventriculomegaly 3 (9.7) 3 (9.1) 3 (5.2) 3 (20.0) 11 (39.3) 9 (16.7)
Spina bifida – – – – – 2 (3.7)
Congenital heart defects 14 (45.2) 16 (48.5) 17 (29.3) 5 (33.3) 15 (53.6) 31 (57.4)
Facial clefts 15 (48.4) 12 (36.4) 15 (25.9) 5 (33.3) 12 (42.9) 19 (35.2)
Micrognathia 3 (9.7) – – 2 (13.3) – 2 (3.7)
Nuchal edema/cystic 7 (22.6) 7 (21.2) 9 (15.5) 1 (6.7) 6 (21.4) –
hygroma
Hydrops fetalis 2 (6.5) 4 (12.1) 4 (6.9) – – –
Omphalocele 7 (22.6) 5 (15.2) 3 (5.2) 2 (13.3) 1 (3.6) –
Diaphragmatic hernia 2 (6.5) – – 2 (13.3) – –
Urinary tract 20 (64.5) 11 (33.3) 12 (20.7) 4 (26.7) 12 (42.9) 9 (16.7)
abnormalities
Abnormal extremities 21 (67.7) 11 (33.3) 8 (13.8) 6 (40.0) – –
Polydactyly – 7 (21.2) – – 2 (7.1) 6 (11.1)
Intrauterine growth 15 (48.4) 16 (48.5) – 4 (26.7) – –
restriction
Echogenic intracardiac – 10 (30.3) – 3 (20.0) 4 (14.3) 2 (3.7)
focus
Echogenic bowel – – – – 5 (17.9) –
Choroid plexus cysts 1 (3.2) – – 1 (6.7) 3 (10.7) –
Single umbilical artery – 8 (24.2) – 2 (13.3) – 5 (9.3)
– = not described.
Taiwan J Obstet Gynecol • September 2009 • Vol 48 • No 3220
C.P. Chen
of cases, including trisomy 13 (n=30), trisomy 18 (n=7)
and other rearrangements (n = 7). In their study, the
prevalence was 4% in fetuses with apparently isolated
HPE and 39% in those with additional abnormalities.
They also reported that HPE was observed in 39% of
fetuses with trisomy 13 (n = 54) and 3% of fetuses with
trisomy 18 (n = 137).
Frequencies of 16.7% (3/18) [29], 17.9% (5/28)
[30], 18.5% (10/54) [31], 25.9% (15/58) [32], 35.5%
(11/31) [33], 39.4% (13/33) [34] and 46.7% (7/15)
[35] have been reported for HPE in fetuses with trisomy
13. In the seven published series on second- and third-
trimester fetal trisomy 13, the mean frequency of HPE
in trisomy 13 was 27.0% (64/237).
Brachycephaly
Brachycephaly is characterized by relative shortening
of the occipital diameter, and is associated with Down
syndrome and Roberts syndrome [28]. Nicolaides et al
[33] reported brachycephaly in 16.1% (5/31) of fetuses
with trisomy 13. In a series of 461 fetuses with chromo-
somal abnormalities at the Harris Birthright Research
Center for Fetal Medicine, Snijders et al [28] found
brachycephaly in 15% of fetuses with trisomy 21
(n = 155), 29% with trisomy 18 (n = 137), 26% with tri-
somy 13 (n = 54), 10% with triploidy (n = 50) and 32%
with Turner syndrome (n = 65).
Microcephaly
Microcephaly occurs in approximately 1 per 1,000 births
and may be caused by chromosomal abnormalities,
genetic syndromes, hemorrhage, infection, teratogens
or radiation [28]. Nicolaides et al [33] reported micro-
cephaly in 9.7% (3/31) of fetuses with trisomy 13,
compared with 12.1% (4/33) reported by Lehman et al
[34]. Snijders et al [28] reported microcephaly in 24%
of trisomy 13 fetuses (n = 54) and in 1% of fetuses with
trisomy 18 (n = 137), and suggested that most fetuses
with trisomy 13 and microcephaly usually have HPE.
DWC and Posterior Fossa 
Abnormalities
DWC refers to a spectrum of abnormalities of the cere-
bellar vermis, cystic dilation of the fourth ventricle, and
enlargement of the cisterna magna, including Dandy-
Walker malformation (DWM; complete or partial agen-
esis of the cerebellar vermis and enlarged posterior
fossa), Dandy-Walker variant (DWV; partial agenesis
of the cerebellar vermis without enlargement of the
posterior fossa), and mega-cisterna magna.
DWM occurs in approximately 1 per 25,000–35,000
pregnancies [36] and is associated with chromosomal
abnormalities, Mendelian mutations, environmental
factors, maternal diabetes, teratogens, congenital infec-
tions, and multifactorial disorders [37–39]. The fre-
quency of chromosomal abnormalities in DWM has
been reported as 14.5% [40], 46% [41] and 55% [42],
with trisomy 18, trisomy 13 and triploidy being the
most common aneuploidies. Hydrocephalus has been
observed in 53% of cases [43], absent corpus callosum
in 19% [36], associated developmental abnormalities
of the central nervous system in 50% [44], and
extracranial abnormalities in 60% [43]. Up to 18 differ-
ent chromosomal abnormalities and 40 genetic 
syndromes have been associated with DWM [38].
Enlargement of the cisterna magna observed in the
third trimester is a clue to aneuploidy, especially 
trisomy 18 [45].
Nyberg et al [42] reported chromosomal abnor-
malities in 54.5% (18/33) of a selected population of
33 fetuses with enlarged cisterna magna, including tri-
somy 18 (n = 12), trisomy 13 (n = 3), Turner syndrome
(n = 1) and other rearrangements (n = 2), and found
that the presence of associated anomalies and absence
of ventricular dilation were most strongly correlated
with chromosomal abnormalities. Chang et al [46]
found chromosomal abnormalities in 53.1% (17/32)
of fetuses with DWV (trisomy 13 [n = 9], trisomy 21
[n = 3], trisomy 18 [n = 2], triploidy [n = 1], and other
rearrangements [n = 2]), and in 31.6% (6/19) of fetuses
with DWM (trisomy 21 [n = 1], trisomy 18 [n = 1],
triploidy [n = 1], tetraploidy [n = 1], mosaicism [n = 2],
and clinical Down syndrome [n = 3]). Ulm et al [47]
found chromosomal abnormalities in 50.0% (7/14) of
fetuses with DWC (DWM [n = 12] and DWV [n = 2])
before 21 weeks of gestation, including trisomy 18
(n = 3), triploidy (n = 2), trisomy 13 (n = 1) and other
rearrangement (n = 1). Ecker et al [41] reported abnor-
malities in 45.8% (11/24) of fetuses with DWM
(triploidy [n=7], trisomy 13 [n=2], trisomy 18 [n=1],
and translocation [n = 1]), and in 32.3% (10/31) of
fetuses with DWV (trisomy 18 [n=4], trisomy 13 [n=1]
and translocations [n = 5]). In a meta-analysis of 101
fetuses with enlarged posterior fossa, Snijders et al
[28] reported chromosomal abnormalities in 44% of
cases, including trisomy 18 (n=22), trisomy 13 (n=10)
and other rearrangements (n = 8). They also reported
that posterior fossa cysts were observed in 15% of 
the fetuses with trisomy 13 (n = 54), 10% with trisomy
18 (n = 137), 6% with triploidy (n = 50) and 1% with 
trisomy 21 (n=155). Nicolaides et al [33] found poste-
rior fossa cysts in 19.4% (6/31) of fetuses with trisomy
13, and Lehman et al [34] reported enlarged cisterna
magna in 15.2% (5/33) of fetuses with trisomy 13, two
of whom were diagnosed at 12–20 weeks of gestation,
and three at 20–32 weeks of gestation. Tongsong et al
[35] found enlarged cisterna magna in 6.7% (1/15) of
fetuses with trisomy 13, and Papp et al [30] reported
posterior fossa cysts in 7.1% (2/28) of fetuses with tri-
somy 13. Watson et al [31] reported DWM in 7.4%
(4/54) of fetuses with trisomy 13 and found abnormal
posterior fossa with enlarged cisterna magna without
an absent vermis in an additional 7.4% (4/54). In the
five published series on second- and third-trimester
fetal trisomy 13, the mean frequency of DWC and 
posterior fossa abnormalities in trisomy 13 was 13.7%
(22/161).
Ventriculomegaly
Ventriculomegaly has a prevalence of about 5–25 per
10,000 births and may be associated with chromoso-
mal abnormalities, genetic defects, intrauterine hem-
orrhage, infection and NTDs [28]. In a meta-analysis of
690 fetuses with prenatally detected ventriculomegaly,
Snijders et al [28] reported chromosomal abnormalities
in 13% of cases, including trisomy 18 (n =23), triploidy
(n = 14), trisomy 21 (n = 13), trisomy 13 (n = 10) and
other rearrangements (n=14). In their study, the preva-
lence was higher in cases with additional abnormalities
than in those with no other detectable abnormalities
(17% vs. 2%), and higher in cases with mild-to-moderate
ventriculomegaly than in those with severe ventricu-
lomegaly (19% vs. 6%). They also reported ventricu-
lomegaly in 18% of fetuses with triploidy (n = 50), 16%
with trisomy 21 (n=155), 14% with trisomy 18 (n=137),
9% with trisomy 13 (n = 54), and 2% with Turner 
syndrome (n = 65).
Nicolaides et al [33] found ventriculomegaly in
9.7% (3/31) of fetuses with trisomy 13. Lehman et al
[34] reported lateral ventricular dilation in 9.1% (3/33)
of fetuses with trisomy 13, of whom two were diag-
nosed at 12–20 weeks of gestation, and three at 20–32
weeks of gestation. De Vigan et al [32] reported hydro-
cephalus in 5.2% (3/58) of fetuses with trisomy 13.
Tongsong et al [35] reported ventriculomegaly in 20.0%
(3/15) of the fetuses with trisomy 13, Picklesimer et al
[29] in 33.3% (6/18), Papp et al [30] in 39.3% (11/28)
and Watson et al [31] in 16.7% (9/54). In the seven
published series on second- and third-trimester fetal
trisomy 13, the mean frequency of ventriculomegaly in
trisomy 13 was 16.0% (38/237).
Neural tube defects
Trisomy 13 can be associated with spina bifida,
encephalocele, and anencephaly. Spina bifida is the
most common NTD associated with trisomy 13.
Encephalocele and anencephaly have occasionally been
reported. Byrne and Warburton [48] reported trisomy
13 in an aborted embryo with encephalocele. Phadke
and Thakur [49] reported prenatal diagnosis of inien-
cephaly, alobar HPE and cyclopia in a fetus with mosaic
trisomy 13, and Halder et al [50] reported mosaic tri-
somy 13 in a fetus with iniencephaly, anencephaly,
facial clefts, single umbilical artery, dilated right side
of the heart, and club foot. Several studies have shown
that NTDs occur in about 8% of trisomy 13 cases
[51–53]. Rodriguez et al [51] found three cases of
spina bifida among 34 trisomy 13 patients (8.8%).
Wyllie et al [52] found one meningocele and two
encephaloceles among 36 trisomy 13 patients (8.3%).
In a study of 25 mid-trimester trisomy 13 fetuses,
Seller [53] found that 8.0% (2/25) had spina bifida,
while Watson et al [31] reported spina bifida in 3.7%
(2/54) of second-trimester fetuses with trisomy 13.
Facial Cleft
Facial clefts, such as cleft lip and/or cleft palate, occur
in approximately 1 per 700 live births and are related
to genetic and environmental factors [28]. The inci-
dence of facial clefts shows marked racial and geo-
graphic variation. For instance, the incidence among
Caucasians, such as the population in the United
Kingdom, is 0.7–0.9 per 1,000 deliveries, while the
incidence is higher (1.5–2.0 per 1,000 deliveries) among
Asians, and lower (0.5 per 1,000 deliveries) among
blacks [54,55]. Chromosomal abnormalities occur
in < 1% of babies with facial clefts [56], but in 30–50%
of fetuses with facial clefts [28,57–59]. Nicolaides 
et al [57] reported chromosomal abnormalities in
48.4% (31/64) of fetuses with facial clefts, including tri-
somy 13 (n=15), trisomy 18 (n=10), trisomy 21 (n=1),
triploidy (n = 1), deletion or translocation (n = 2) and
other rearrangements (n = 2). In a meta-analysis of
118 fetuses with prenatally diagnosed facial clefts,
Snijders et al [28] reported chromosomal abnormali-
ties in 40%, including trisomy 13 (n = 25), trisomy 18
(n = 16) and other rearrangements (n = 6), while in a
study of 461 fetuses with chromosomal abnormalities
[28], they reported facial clefts in 39% of fetuses with
trisomy 13 (n = 54), 10% with trisomy 18 (n = 137), 
2% with triploidy (n = 50) and 1% with trisomy 21 
(n = 155).
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Trisomy 13 accounts for up to 50–70% of chromo-
somal abnormalities associated with facial clefts
[28,57–60]. Clementi et al [59] reported 74 fetuses
with prenatally detected facial clefts and chromoso-
mal abnormalities, including trisomy 13 (n = 41), tri-
somy 18 (n = 13), autosomal deletions (n = 5), trisomy
21 (n = 3), triploidy (n = 4) and other rearrangements
(n = 8), while Stoll et al [61] reported 27 fetuses with
prenatally detected facial clefts and chromosomal ab-
normalities, including trisomy 13 (n=11), trisomy 18
(n = 13), del(4p) (n = 1), r(15) (n = 1), and dup(12p)
(n = 1).
Chromosomal abnormalities vary with the type of
facial cleft [58,59,62]. Nyberg et al [58] reported chro-
mosomal abnormalities in 30.8% (20/65) of fetuses
and neonates with facial clefts (unilateral cleft lip [n=5],
unilateral cleft lip and palate [n =15], bilateral cleft lip
and palate [n = 20], median cleft lip and palate [n =
21], and cleft with amniotic bands [n = 4]), including
trisomy 13 (n = 14), trisomy 18 (n = 2), 45,X (n = 1),
mosaic trisomy 22 (n = 1), del(6)(p22) (n = 1), and
der(10)t(10;15)(q21.2;q15) (n = 1). They found chro-
mosomal abnormalities in none of the cases with uni-
lateral cleft lip (0/5), in 20.0% (3/15) with unilateral
cleft lip and cleft palate (trisomy 18 [n=1], 45,X [n=1],
and mosaic trisomy 22 [n=1]), 30.0% (6/20) with bilat-
eral cleft lip and palate (trisomy 13 [n =4], del(6)(p22)
[n =1] and der(10)t(10;15)(q21.2;q15) [n =1]), 52.4%
(11/21) with median cleft lip and palate (trisomy 13
[n =10] and trisomy 18 [n =1]), and in none with cleft
associated with amniotic bands (0/4). In their study,
the types of facial clefts in the 14 cases with trisomy 13
included median cleft lip and palate (n =10) and bilat-
eral cleft lip and palate (n = 4), and the two cases with
trisomy 18 had median cleft lip and palate (n = 1) and
unilateral cleft lip and palate (n = 1).
Bergé et al [60] reported chromosomal abnormali-
ties in 51.4% (36/70) of fetuses with prenatally detected
facial cleft (cleft lip [n=3], unilateral cleft lip and palate
[n = 25], bilateral cleft lip and palate [n = 29], median
cleft [n=11], and isolated cleft palate [n=2]), including
trisomy 13 (n = 28), trisomy 18 (n = 6), triploidy (n =
1), and marker chromosome (n = 1). They found chro-
mosomal abnormalities in none of the fetuses with
unilateral cleft lip (0/3), in 32.0% (8/25) with unilat-
eral cleft lip and cleft palate (trisomy 13 [n = 6], tri-
somy 18 [n =1] and triploidy [n =1]), 58.6% (17/29)
with bilateral cleft lip and palate (trisomy 13 [n = 12],
trisomy 18 [n = 4], and marker chromosome [n = 1]),
81.8% (9/11) with median cleft lip and palate (trisomy
13 [n = 8] and trisomy 18 [n = 1]), and in 2 of 2 with
isolated cleft palate (both trisomy 13). The types of
facial clefts in the 28 cases with trisomy 13 in their
study were bilateral cleft lip and palate (n = 12),
median cleft (n = 8), unilateral cleft lip and palate (n =
6) and isolated cleft palate (n = 2), and in the six cases
with trisomy 18 were bilateral cleft lip and palate (n =
4), median cleft (n = 1) and unilateral cleft lip and
palate (n = 1). The triploid case had unilateral cleft lip
and palate, and the case with the marker chromosome
had bilateral cleft lip and palate.
Frequencies of 25.9% (15/58) [32], 33.3% (5/15)
[35], 33.3% (6/18) [29], 35.2% (19/54) [31], 36.4%
(12/33) [34], 42.9% (12/28) [30] and 48.4% (15/31)
[33] have been reported for facial clefts in fetuses with
trisomy 13. In the seven published series on second- and
third-trimester fetal trisomy 13, the mean frequency of
facial cleft in trisomy 13 was 35.4% (84/237).
Micrognathia
Micrognathia occurs in approximately 1 per 1,000 births
and is a nonspecific finding associated with a wide range
of genetic syndromes and chromosomal abnormalities
[63]. The risk of chromosomal abnormalities, mainly tri-
somy 18 and triploidy, may be as high as 38–66% in
fetuses with micrognathia [57]. Nicolaides et al [57]
reported that 66.1% (37/56) of fetuses with microg-
nathia had chromosomal abnormalities, including tri-
somy 18 (n = 21), triploidy (n = 9), trisomy 13 (n = 3),
deletion or translocation (n = 3) and other rearrange-
ments (n=1). Snijders et al [28] reported micrognathia
in 53% of fetuses with trisomy 18 (n = 137), 44% with
triploidy (n = 50), 9% with trisomy 13 (n = 54) and 1%
with trisomy 21 (n = 155). Frequencies of 3.7% (2/54)
[31], 9.7% (3/31) [33] and 13.3% (2/15) [35] have
been reported for micrognathia in fetuses with trisomy
13. In three published series on second- and third-
trimester fetal trisomy 13, the mean frequency of
micrognathia in trisomy 13 was 7.0% (7/100).
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